SRC and acute lymphoblastic leukemia: GZD824 suppressed both SRC and PI3K/AKT in Ph– cells, which is consistent with other reports that inhibition of SRC kinase or PI3K/AKT signaling suppresses ALL cells in vitro and in vivo [11, 32–34].